Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 151.1197 USD 1.01%
Market Cap: 364.2B USD
Have any thoughts about
Johnson & Johnson?
Write Note

During the last 3 months Johnson & Johnson insiders have not bought any shares, and sold 1.2m USD worth of shares. The stock price has dropped by 2% over this period (open performance analysis).

The last transaction was made on Feb 25, 2025 by Decker Robert J (Chief Financial Officer) , who sold 1.2m USD worth of JNJ shares.

Last Transactions:
Decker Robert J
Chief Financial Officer
$-1.2m
Schmid Timothy
Chief Financial Officer (CFO)
$-62.9k
Wolk Joseph J
General Counsel
$-2m
Weinberger Mark A
Director since 2023
$+147.2k
Decker Robert J
Chief Financial Officer
$-930.1k
Broadhurst Vanessa
Executive Vice President, Global Corporate Affairs
$-1.4m
Taubert Jennifer L
Executive Vice President, Worldwide Chairman, Pharmaceuticals
$-9.3m
Hait William
$-2.5m
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-3.4m
Swanson James D.
$-164.2k
Wolk Joseph J
General Counsel
$-332.9k
Mcevoy Ashley
Executive Vice President and Worldwide Chairman, MedTech
$-246.5k
Taubert Jennifer L
Executive Vice President, Worldwide Chairman, Pharmaceuticals
$-13.6m
Decker Robert J
Chief Financial Officer
$-3m
Wengel Kathryn E
Executive Vice President and Chief Global Supply Chain Officer
$-2.8m
Mongon Thibaut
$-2.9m
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-17.2k
Hait William
Global Therapeutic Head, Oncology
$-203.6k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-4.5k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-90.7k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-34.3k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-63.5k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-142.2k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-33.9k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-5.8k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-131.6k
Fasolo Peter
Executive Vice President, Chief Human Resources Officer
$-213.9k
Wengel Kathryn E
Executive Vice President and Chief Global Supply Chain Officer
$-17.3k
Decker Robert J
Chief Financial Officer
$-1.5m
Hait William
Global Therapeutic Head, Oncology
$-18.4k
Mongon Thibaut
$-1.1k
Mongon Thibaut
Group CIO (Chief Information Officer)
$-250.3k
View All Transactions

During the last 3 months Johnson & Johnson insiders have not bought any shares, and sold 1.2m USD worth of shares. The stock price has dropped by 2% over this period (open performance analysis).

The last transaction was made on Feb 25, 2025 by Decker Robert J (Chief Financial Officer) , who sold 1.2m USD worth of JNJ shares.

Sold
0-3
months
1.2m USD
2
3-6
months
2m USD
1
6-9
months
930.1k USD
1
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
1
147.2k USD
6-9
months
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Johnson & Johnson
Insider Trading Chart

Johnson & Johnson
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Johnson & Johnson
Last Insider Transactions

Global
Insiders Monitor

Johnson & Johnson
Glance View

Economic Moat
Wide
Market Cap
363.5B USD
Industry
Pharmaceuticals

Founded in 1886, Johnson & Johnson began its journey with a commitment to revolutionizing healthcare, starting with the sterile surgical dressings it produced to reduce infections in hospitals. Over the decades, this vision expanded into a global healthcare powerhouse, intricate in its operation yet unified in its mission to improve lives. Johnson & Johnson's business model is built on three core segments: pharmaceuticals, medical devices, and consumer health products. Each segment harnesses the synergy of innovation, research, and a deep understanding of customer needs. The pharmaceutical division, one of its most robust, thrives on producing treatments for various medical conditions, including immunology, oncology, and neuroscience. It is in this domain that cutting-edge research and development efforts translate into high-margin therapies, driving substantial portions of the company's revenue. Beyond pharmaceuticals, the medical devices segment forms a pillar of Johnson & Johnson's operations, offering a spectrum of products essential for surgeries, orthopedics, and vision care. These devices are integral for modern healthcare practices, with their premium positioning contributing significantly to the company’s financial health. Meanwhile, Johnson & Johnson's consumer health division addresses everyday wellness needs, with iconic brands like Band-Aid, Tylenol, and Neutrogena. This segment leverages global brand recognition and trust to generate steady, albeit lower-margin, income streams. Together, these segments compose a diversified revenue platform, buffered against sector-specific downturns and positioning Johnson & Johnson as a formidable entity in global healthcare markets.

JNJ Intrinsic Value
161.1104 USD
Undervaluation 6%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top